Delivery Order SPE2DB20D6037-SPE2DB23FD0RN

Award Date 8/10/23
Potential Completion Date 8/11/23
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a firm fixed-price delivery order valued at $1,168.80. It was issued by the Defense Logistics Agency (DLA) and covers the supply of Freestyle Libre 2 Sensors, a medical device used for continuous glucose monitoring. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order (SPE2DB20D6037|SPE2DB24FC9TP) valued at $1,263.81 for the supply of Freestyle Libre 2 sensors. The contract is a firm fixed-price arrangement with the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 17, 2023. DMS Pharmaceutical Group is an established federal contractor that specializes in providing a wide range of pharmaceutical...
This is a firm fixed-price delivery order (SPE2DB23FD0ET) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,339.62 contract is for the delivery of Freestyle Libre 2 sensors, which are medical devices used for continuous glucose monitoring. The award is part of a larger indefinite delivery contract (SPE2DB20D6037) with a ceiling value of up to $499,999,999 that DMS Pharmaceutical Group holds with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,447.63 contract is for the delivery of Freestyle Libre 2 sensors, with a performance period ending on October 23, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,228.53, is for the delivery of Freestyle Libre 2 sensors. It is not associated with any set-aside designation. The contract is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,541.39 fixed-price contract is for the supply of Freestyle Libre 2 Sensors, a continuous glucose monitoring device, with a period of performance through August 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,936.02 firm fixed-price delivery order is for the supply of Freestyle Libre 2 sensors, a continuous glucose monitoring device used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Freestyle Libre 2 sensors, a medical device used for glucose monitoring, to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,146.60 and a completion date of February 11, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Freestyle Libre 2 glucose sensors. The $1,214.41 firm-fixed-price delivery order has a completion date of December 9, 2024 and is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $4,049.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Freestyle Libre 2 Sensors, a type of continuous glucose monitoring device, with a period of performance through January 27, 2025. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB23FD0RN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $2,113.13 firm fixed-price delivery order is for the supply of Freestyle Libre 2 sensors, a type of continuous glucose monitoring device.

The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. DMS Pharmaceutical Group also holds separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying its position as a key supplier in the federal pharmaceutical supply chain.

The contract award does not have a set-aside designation. The ultimate completion date for this delivery order is August 11, 2023.

Generated 10/23/24, 9:31 AM